ISGylation - a key to lock the cell gates for preventing the spread of threats

Journal of Cell Science

Volumn 130, Issue 18, 2017, Pages 2961-2969

  Villarroya Beltri, Carolina ^a,b,c   Guerra, Susana ^b   Sánchez Madrid, Francisco ^a,b,c  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CIBERCV   (Spain)

Author keywords

Exosomes; ISG15; Pathogen; Post translational modification; Ubiquitin like

Indexed keywords

INTERFERON STIMULATED GENE 15; PROTEIN KINASE R; UBIQUITIN; UNCLASSIFIED DRUG; INTERFERON;

BACTERIAL INFECTION; CANCER GROWTH; CANCER PREVENTION; CELL FUSION; CELLULAR SECRETION; CONJUGATION; EXOSOME; HUMAN; INFECTION PREVENTION; LYSOSOME; MULTIVESICULAR BODY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; VIRUS INFECTION; ANIMAL; BIOLOGICAL MODEL; CELLS; METABOLISM; NEOPLASM;

ANIMALS; BACTERIAL INFECTIONS; CELLS; HUMANS; INTERFERONS; MODELS, BIOLOGICAL; NEOPLASMS; VIRUS DISEASES;

EID: 85029445495     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.205468     Document Type: Review

References (94)

1. Abrahamsen, H., Stenmark, H. and Platta, H. W. (2012). Ubiquitination and phosphorylation of Beclin 1 and its binding partners: tuning class III phosphatidylinositol 3-kinase activity and tumor suppression. FEBS Lett. 586, 1584-1591
2. Arimoto, K.-I., Lochte, S., Stoner, S. A., Burkart, C., Zhang, Y., Miyauchi, S., Wilmes, S., Fan, J.-B., Heinisch, J. J., Li, Z. et al. (2017). STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling. Nat. Struct. Mol. Biol. 24, 279-289
3. Arnaud, N., Dabo, S., Akazawa, D., Fukasawa, M., Shinkai-Ouchi, F., Hugon, J., Wakita, T. and Meurs, E. F. (2011). Hepatitis C virus reveals a novel early control in acute immune response. PLoS Pathog. 7, e1002289
4. Baker, S., Polanco, J. C. and Götz, J. (2016). Extracellular vesicles containing P301L mutant tau accelerate pathological tau phosphorylation and oligomer formation but do not seed mature neurofibrillary tangles in ALZ17 mice. J. Alzheimers Dis. 54, 1207-1217
5. Basters, A., Geurink, P. P., Röcker, A., Witting, K. F., Tadayon, R., Hess, S., Semrau, M. S., Storici, P., Ovaa, H., Knobeloch, K.-P. et al. (2017). Structural basis of the specificity of USP18 toward ISG15. Nat. Struct. Mol. Biol. 24, 270-278
6. Bogunovic, D., Byun, M., Durfee, L. A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A. V., Adimi, P. et al. (2012). Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337, 1684-1688
7. Burks, J., Reed, R. E. and Desai, S. D. (2014). ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene 33, 794-803
8. Burks, J., Reed, R. E. and Desai, S. D. (2015). Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget 6, 7221-7231
9. Cerikan, B., Shaheen, R., Colo, G. P., Glasser, C., Hata, S., Knobeloch, K.-P., Alkuraya, F. S., Fässler, R. and Schiebel, E. (2016). Cell-intrinsic adaptation arising from chronic ablation of a key Rho GTPase regulator. Dev. Cell 39, 28-43
10. Colombo, M., Moita, C., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L. F., Thery, C. and Raposo, G. (2013). Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J. Cell Sci. 126, 5553-5565
11. Chairatvit, K., Wongnoppavich, A. and Choonate, S. (2012). Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-alpha via type I interferon-dependent and-independent pathways. Mol. Cell. Biochem. 368, 195-201
12. Chen, R. H., Du, Y., Han, P., Wang, H. B., Liang, F. Y., Feng, G. K., Zhou, A. J., Cai, M. Y., Zhong, Q., Zeng, M. S. et al. (2016). ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma. Oncotarget 7, 16910-16922
13. Daczkowski, C. M., Dzimianski, J. V., Clasman, J. R., Goodwin, O., Mesecar, A. D. and Pegan, S. D. (2017). Structural insights into the interaction of coronavirus papain-like proteases and interferon-stimulated gene Product 15 from different species. J. Mol. Biol. 429, 1661-1683
14. Dai, L., Bai, L., Lin, Z., Qiao, J., Yang, L., Flemington, E. K., Zabaleta, J. and Qin, Z. (2016). Transcriptomic analysis of KSHV-infected primary oral fibroblasts: the role of interferon-induced genes in the latency of oncogenic virus. Oncotarget 7, 47052-47060
15. Deng, X., Agnihothram, S., Mielech, A. M., Nichols, D. B.,Wilson, M.W., StJohn, S. E., Larsen, S. D., Mesecar, A. D., Lenschow, D. J., Baric, R. S. et al. (2014). A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses. J. Virol. 88, 11825-11833
16. Desai, S. D. (2015). ISG15: a double edged sword in cancer. Oncoimmunology 4, e1052935
17. Desai, S. D., Haas, A. L., Wood, L. M., Tsai, Y. C., Pestka, S., Rubin, E. H., Saleem, A., Nur, E. K. A. and Liu, L. F. (2006). Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res. 66, 921-928
18. Desai, S. D., Wood, L. M., Tsai, Y.-C., Hsieh, T.-S., Marks, J. R., Scott, G. L., Giovanella, B. C. and Liu, L. F. (2008). ISG15 as a novel tumor biomarker for drug sensitivity. Mol. Cancer Ther. 7, 1430-1439
19. Desai, S. D., Reed, R. E., Burks, J.,Wood, L. M., Pullikuth, A. K., Haas, A. L., Liu, L. F., Breslin, J. W., Meiners, S. and Sankar, S. (2012). ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp. Biol. Med. (Maywood) 237, 38-49
20. Desai, S. D., Reed, R. E., Babu, S. and Lorio, E. A. (2013). ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells. J. Biol. Chem. 288, 2388-2402
21. Dos Santos, P. F. and Mansur, D. S. (2017). Beyond ISGlylation: functions of free intracellular and extracellular ISG15. J. Interferon Cytokine Res. 37, 246-253
22. Doyle, S. E., Vaidya, S. A., O'Connell, R., Dadgostar, H., Dempsey, P.W., Wu, T.-T., Rao, G., Sun, R., Haberland, M. E., Modlin, R. L. et al. (2002). IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263
23. Durfee, L. A., Lyon, N., Seo, K. and Huibregtse, J. M. (2010). The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol. Cell 38, 722-732
24. Eitan, E., Hutchison, E. R., Marosi, K., Comotto, J., Mustapic, M., Nigam, S. M., Suire, C., Maharana, C., Jicha, G. A., Liu, D., et al. (2016). Extracellular vesicleassociated Aβ mediates trans-neuronal bioenergetic and Ca2+-handling deficits in Alzheimer's disease models. NPJ Aging Mech Dis. 2,16019
25. Fan, J.-B., Arimoto, K.-I., Motamedchaboki, K., Yan, M., Wolf, D. A. and Zhang, D.-E. (2015a). Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis. Sci. Rep. 5, 12704
26. Fan, J.-B., Miyauchi-Ishida, S., Arimoto, K.-A., Liu, D., Yan, M., Liu, C.-W., Gyorffy, B. and Zhang, D.-E. (2015b). Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation. Proc. Natl. Acad. Sci. USA 112, 14313-14318
27. Feng, Q., Sekula, D., Guo, Y., Liu, X., Black, C. C., Galimberti, F., Shah, S. J., Sempere, L. F., Memoli, V., Andersen, J. B. et al. (2008). UBE1L causes lung cancer growth suppression by targeting cyclin D1. Mol. Cancer Ther. 7, 3780-3788
28. Frias-Staheli, N., Giannakopoulos, N. V., Kikkert, M., Taylor, S. L., Bridgen, A., Paragas, J., Richt, J. A., Rowland, R. R., Schmaljohn, C. S., Lenschow, D. J. et al. (2007). Ovarian tumor domain-containing viral proteases evade ubiquitinand ISG15-dependent innate immune responses. Cell Host Microbe. 2, 404-416
29. Goldmann, T., Zeller, N., Raasch, J., Kierdorf, K., Frenzel, K., Ketscher, L., Basters, A., Staszewski, O., Brendecke, S. M., Spiess, A. et al. (2015). USP18 lack in microglia causes destructive interferonopathy of the mouse brain. EMBO J. 34, 1612-1629
30. Guerra, S., Cáceres, A., Knobeloch, K.-P., Horak, I. and Esteban, M. (2008). Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 4, e1000096
31. Guo, B. B., Bellingham, S. A. and Hill, A. F. (2016). Stimulating the release of exosomes increases the intercellular transfer of prions. J. Biol. Chem. 291, 5128-5137
32. Haas, A. L., Ahrens, P., Bright, P. M. and Ankel, H. (1987). Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 262, 11315-11323
33. Hummer, B. T., Li, X.-L. and Hassel, B. A. (2001). Role for p53 in gene induction by double-stranded RNA. J. Virol. 75, 7774-7777
34. Jeon, Y. J., Jo, M. G., Yoo, H. M., Hong, S.-H., Park, J.-M., Ka, S. H., Oh, K. H., Seol, J. H., Jung, Y. K. and Chung, C. H. (2012). Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. J. Clin. Invest. 122, 2622-2636
35. Katzenell, S. and Leib, D. A. (2016). Herpes simplex virus and interferon signaling induce novel autophagic clusters in sensory neurons. J. Virol. 90, 4706-4719
36. Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A. and Yao, T.-P. (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727-738
37. Ketscher, L., Hannss, R., Morales, D. J., Basters, A., Guerra, S., Goldmann, T., Hausmann, A., Prinz, M., Naumann, R., Pekosz, A. et al. (2015). Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. Proc. Natl. Acad. Sci. USA 112, 1577-1582
38. Kiessling, A., Hogrefe, C., Erb, S., Bobach, C., Fuessel, S.,Wessjohann, L. and Seliger, B. (2009). Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene 28, 2606-2620
39. Kim, Y. J., Kim, E. T., Kim, Y.-E., Lee,M. K., Kwon, K. M., Kim, K. I., Stamminger, T. and Ahn, J.-H. (2016). Consecutive inhibition of ISG15 expression and ISGylation by cytomegalovirus regulators. PLoS Pathog. 12, e1005850
40. Knobeloch, K. P., Utermohlen, O., Kisser, A., Prinz, M. and Horak, I. (2005). Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell. Biol. 25, 11030-11034
41. Kuang, Z., Seo, E. J. and Leis, J. (2011). Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J. Virol. 85, 7153-7161
42. Kunadt, M., Eckermann, K., Stuendl, A., Gong, J., Russo, B., Strauss, K., Rai, S., Kügler, S., Falomir Lockhart, L., Schwalbe, M. et al. (2015). Extracellular vesicle sorting of alpha-Synuclein is regulated by sumoylation. Acta Neuropathol. 129, 695-713
43. Lee, J.-Y., Koga, H., Kawaguchi, Y., Tang, W., Wong, E., Gao, Y.-S., Pandey, U. B., Kaushik, S., Tresse, E., Lu, J. et al. (2010). HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 29, 969-980
44. Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt, R. E., Garcia-Sastre, A. et al. (2007). IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. USA. 104, 1371-1376
45. Li, J., Peet, G.W., Balzarano, D., Li, X., Massa, P., Barton, R.W. and Marcu, K. B. (2001). Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276, 18579-18590
46. Li, C., Wang, J., Zhang, H., Zhu, M., Chen, F., Hu, Y., Liu, H. and Zhu, H. (2014). Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma. Oncotarget 5, 8429-8441
47. Liu, C., Chang, R., Yao, X., Qiao, W. T. and Geng, Y. Q. (2009). ISG15 expression in response to double-stranded RNA or LPS in cultured Fetal bovine lung (FBL) cells. Vet. Res. Commun. 33, 723-733
48. Liu, F., Gao, X., Wang, J., Gao, C., Li, X., Li, X., Gong, X. and Zeng, X. (2016). Transcriptome sequencing to identify transcription factor regulatory network and alternative splicing in endothelial cells under VEGF stimulation. J. Mol. Neurosci. 58, 170-177
49. Loeb, K. R. and Haas, A. L. (1992). The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267, 7806-7813
50. Lou, Z.,Wei, J., Riethman, H., Baur, J. A., Voglauer, R., Shay, J.W. and Wright, W. E. (2009). Telomere length regulates ISG15 expression in human cells. Aging (Albany NY) 1, 608-621
51. Malakhova, O. A., Kim, K. I. I., Luo, J.-K., Zou, W., Kumar, K. G. S., Fuchs, S. Y., Shuai, K. and Zhang, D.-E. (2006). UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25, 2358-2367
52. Maragno, A. L., Pironin, M., Alcalde, H., Cong, X., Knobeloch, K.-P., Tangy, F., Zhang, D.-E., Ghysdael, J. and Quang, C. T. (2011). ISG15 modulates development of the erythroid lineage. PLoS ONE 6, e26068
53. Meuwissen, M. E. C., Schot, R., Buta, S., Oudesluijs, G., Tinschert, S., Speer, S. D., Li, Z., van Unen, L., Heijsman, D., Goldmann, T. et al. (2016). Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. J. Exp. Med. 213, 1163-1174
54. Mittelbrunn, M. and Sanchez-Madrid, F. (2012). Intercellular communication: diverse structures for exchange of genetic information. Nat. Rev. Mol. Cell Biol. 13, 328-335
55. Morales, D. J., Monte, K., Sun, L., Struckhoff, J. J., Agapov, E., Holtzman, M. J., Stappenbeck, T. S. and Lenschow,D. J. (2015). Novel mode of ISG15-mediated protection against influenza Avirus and Sendai virus in mice. J. Virol. 89, 337-349
56. Nakashima, H., Nguyen, T., Goins, W. F. and Chiocca, E. A. (2015). Interferonstimulated Gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1/p62. J. Biol. Chem. 290, 1485-1495
57. Nakka, V. P., Lang, B. T., Lenschow, D. J., Zhang, D.-E., Dempsey, R. J. and Vemuganti, R. (2011). Increased cerebral protein ISGylation after focal ischemia is neuroprotective. J. Cereb. Blood Flow Metab. 31, 2375-2384
58. Okumura, F., Zou, W. and Zhang, D.-E. (2007). ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev. 21, 255-260
59. Okumura, A., Pitha, P. M. and Harty, R. N. (2008a). ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. USA 105, 3974-3979
60. Okumura, F., Lenschow, D. J. and Zhang, D.-E. (2008b). Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation. J. Biol. Chem. 283, 24484-24488
61. Okumura, F., Okumura, A. J., Uematsu, K., Hatakeyama, S., Zhang, D.-E. and Kamura, T. (2013). Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation. J. Biol. Chem. 288, 2839-2847
62. Osiak, A., Utermohlen, O., Niendorf, S., Horak, I. and Knobeloch, K.-P. (2005). ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell. Biol. 25, 6338-6345
63. Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Overvatn, A., Bjorkoy, G. and Johansen, T. (2007). p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131-24145
64. Park, J. M., Yang, S.W., Yu, K. R., Ka, S. H., Lee, S.W., Seol, J. H., Jeon, Y. J. and Chung, C. H. (2014). Modification of PCNA by ISG15 plays a crucial role in termination of error-prone translesion DNA synthesis. Mol. Cell 54, 626-638
65. Park, J. H., Yang, S.W., Park, J. M., Ka, S. H., Kim, J.-H., Kong, Y.-Y., Jeon, Y. J., Seol, J. H. and Chung, C. H. (2016). Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat. Commun. 7, 12513
66. Pincetic, A., Kuang, Z., Seo, E. J. and Leis, J. (2010). The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 84, 4725-4736
67. Pitha-Rowe, I., Hassel, B. A. and Dmitrovsky, E. (2004). Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J. Biol. Chem. 279, 18178-18187
68. Quek, C. and Hill, A. F. (2017). The role of extracellular vesicles in neurodegenerative diseases. Biochem. Biophys. Res. Commun. 483, 1178-1186
69. Radoshevich, L., Impens, F., Ribet, D., Quereda, J. J., Nam Tham, T., Nahori, M. A., Bierne, H., Dussurget, O., Pizarro-Cerda, J., Knobeloch, K. P. et al. (2015). ISG15 counteracts Listeria monocytogenes infection. Elife 4, e06848
70. Raposo, G. and Stoorvogel, W. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383
71. Rodriguez, M. R., Monte, K., Thackray, L. B. and Lenschow, D. J. (2014). ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle. J. Virol. 88, 9277-9286
72. Rossi, J. L., Todd, T., Daniels, Z., Bazan, N. G. and Belayev, L. (2015). Interferonstimulated Gene 15 upregulation precedes the development of blood-brain barrier disruption and cerebral edema after traumatic brain injury in young mice. J. Neurotrauma 32, 1101-1108
73. Sadler, A. J. and Williams, B. R. G. (2008). Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568
74. Sainz, B., Jr, Martin, B., Tatari, M., Heeschen, C. and Guerra, S. (2014). ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells. Cancer Res. 74, 7309-7320
75. Sanyal, S., Ashour, J., Maruyama, T., Altenburg, A. F., Cragnolini, J. J., Bilate, A., Avalos, A. M., Kundrat, L., García-Sastre, A. and Ploegh, H. L. (2013). Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection. Cell Host Microbe 14, 510-521
76. Schmeisser, H., Fey, S. B., Horowitz, J., Fischer, E. R., Balinsky, C. A., Miyake, K., Bekisz, J., Snow, A. L. and Zoon, K. C. (2013). Type I interferons induce autophagy in certain human cancer cell lines. Autophagy 9, 683-696
77. Sen, G. C. and Sarkar, S. N. (2007). The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA, and viruses. Curr. Top. Microbiol. Immunol. 316, 233-250
78. Shi, H. X., Yang, K., Liu, X., Liu, X. Y.,Wei, B., Shan, Y. F., Zhu, L. H. andWang, C. (2010). Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 30, 2424-2436
79. Skaug, B. and Chen, Z. J. (2010). Emerging role of ISG15 in antiviral immunity. Cell 143, 187-190
80. Speer, S. D., Li, Z., Buta, S., Payelle-Brogard, B., Qian, L., Vigant, F., Rubino, E., Gardner, T. J., Wedeking, T., Hermann, M. et al. (2016). ISG15 deficiency and increased viral resistance in humans but not mice. Nat. Commun. 7, 11496
81. Takeuchi, T. and Yokosawa, H. (2005). ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem. Biophys. Res. Commun. 336, 9-13
82. Taylor, J. L., D'Cunha, J., Tom, P., O'Brien, W. J. and Borden, E. C. (1996). Production of ISG-15, an interferon-inducible protein, in human corneal cells. J. Interferon Cytokine Res. 16, 937-940
83. Villarreal, D. O.,Wise, M. C., Siefert, R. J., Yan, J.,Wood, L. M. andWeiner, D. B. (2015). Ubiquitin-like molecule ISG15 acts as an immune adjuvant to enhance antigen-specific CD8 T-cell tumor immunity. Mol. Ther. 23, 1653-1662
84. Villarroya-Beltri, C., Baixauli, F., Mittelbrunn, M., Fernandez-Delgado, I., Torralba, D., Moreno-Gonzalo, O., Baldanta, S., Enrich, C., Guerra, S. and Sanchez-Madrid, F. (2016). ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat. Commun. 7, 13588
85. Werneke, S. W., Schilte, C., Rohatgi, A., Monte, K. J., Michault, A., Arenzana-Seisdedos, F., Vanlandingham, D. L., Higgs, S., Fontanet, A., Albert, M. L. et al. (2011). ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 7, e1002322
86. Wood, L. M., Pan, Z. K., Seavey, M. M., Muthukumaran, G. and Paterson, Y. (2012). The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy. Cancer Immunol. Immunother. 61, 689-700
87. Xu, D., Zhang, T., Xiao, J., Zhu, K., Wei, R., Wu, Z., Meng, H., Li, Y. and Yuan, J. (2015). Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon. Autophagy 11, 617-628
88. Yan, J., Seibenhener, M. L., Calderilla-Barbosa, L., Diaz-Meco, M. T., Moscat, J., Jiang, J.,Wooten, M.W. andWooten, M. C. (2013). SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity. PLoS ONE 8, e76016
89. Yanguez, E., Garcia-Culebras, A., Frau, A., Llompart, C., Knobeloch, K. P., Gutierrez-Erlandsson, S., Garcia-Sastre, A., Esteban, M., Nieto, A. and Guerra, S. (2013). ISG15 regulates peritoneal macrophages functionality against viral infection. PLoS Pathog. 9, e1003632
90. Yeh, Y. H., Yang, Y. C., Hsieh, M. Y., Yeh, Y. C. and Li, T. K. (2013). A negative feedback of the HIF-1alpha pathway via interferon-stimulated gene 15 and ISGylation. Clin. Cancer Res. 19, 5927-5939
91. Yuan,W. and Krug, R. M. (2001). Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20, 362-371
92. Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S. D., Yuan, C., Volpi, S., Li, Z., Sanal, O., Mansouri, D. et al. (2015). Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and autoinflammation. Nature 517, 89-93
93. Zhao, C., Hsiang, T. Y., Kuo, R. L. and Krug, R. M. (2010). ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl. Acad. Sci. USA 107, 2253-2258
94. Zhao, C., Sridharan, H., Chen, R., Baker, D. P.,Wang, S. and Krug, R. M. (2016). Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins. Nat. Commun. 7, 12754